Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological, and pathological d
Pharmaceuticals | Free Full-Text | Mitochondrion-Targeted NIR Therapeutic Agent Suppresses Melanoma by Inducing Apoptosis and Cell Cycle Arrest via E2F/Cyclin/CDK Pathway
Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological and pathological disease in a Syrian hamster model of COVID-19 | bioRxiv
Pharmaceuticals | Free Full-Text | Mitochondrion-Targeted NIR Therapeutic Agent Suppresses Melanoma by Inducing Apoptosis and Cell Cycle Arrest via E2F/Cyclin/CDK Pathway
NanoMice #1 Stroje | ~Kasia - YouTube
Non-Viral Vector-Mediated Gene Therapy for ALS: Challenges and Future Perspectives | Molecular Pharmaceutics
Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological and pathological disease in a Syrian hamster model of COVID-19 | bioRxiv
Lighting up forensic science by aggregation-induced emission: A review - ScienceDirect
Dual-Key-and-Lock” Ruthenium Complex Probe for Lysosomal Formaldehyde in Cancer Cells and Tumors | Journal of the American Chemical Society
Research looks at inflammatory nature of lipid nanoparticle component in mRNA vaccines
Therapy used on mice may transform spinal injury treatments, say scientists | Medical research | The Guardian
Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological and pathological disease in a Syrian hamster model of COVID-19 | bioRxiv
Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological and pathological disease in a Syrian hamster model of COVID-19 | bioRxiv
Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological, and pathological d
when Nanomeets Bio
Lighting up forensic science by aggregation-induced emission: A review - ScienceDirect
Présentation PowerPoint
Dual-Key-and-Lock” Ruthenium Complex Probe for Lysosomal Formaldehyde in Cancer Cells and Tumors | Journal of the American Chemical Society
Non-Viral Vector-Mediated Gene Therapy for ALS: Challenges and Future Perspectives | Molecular Pharmaceutics
Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological, and pathological d
MnCO3@BSA-ICG nanoparticles as a magnetic resonance/photoacoustic dual-modal contrast agent for functional imaging of acute ischemic stroke - ScienceDirect
Pharmaceuticals | Free Full-Text | Mitochondrion-Targeted NIR Therapeutic Agent Suppresses Melanoma by Inducing Apoptosis and Cell Cycle Arrest via E2F/Cyclin/CDK Pathway
Pharmaceuticals | Free Full-Text | Mitochondrion-Targeted NIR Therapeutic Agent Suppresses Melanoma by Inducing Apoptosis and Cell Cycle Arrest via E2F/Cyclin/CDK Pathway
Dual-Key-and-Lock” Ruthenium Complex Probe for Lysosomal Formaldehyde in Cancer Cells and Tumors | Journal of the American Chemical Society
Pharmaceuticals | Free Full-Text | Mitochondrion-Targeted NIR Therapeutic Agent Suppresses Melanoma by Inducing Apoptosis and Cell Cycle Arrest via E2F/Cyclin/CDK Pathway
Researchers develop self-assembling nanoparticle SARS-CoV-2 vaccines
Présentation PowerPoint
.jpg "Nanobodies from nanomice and llamas show potent neutralizing activity against SARS-CoV-2 variants")
Nanobodies from nanomice and llamas show potent neutralizing activity against SARS-CoV-2 variants
Dual-Key-and-Lock” Ruthenium Complex Probe for Lysosomal Formaldehyde in Cancer Cells and Tumors | Journal of the American Chemical Society
Pharmaceuticals | Free Full-Text | Mitochondrion-Targeted NIR Therapeutic Agent Suppresses Melanoma by Inducing Apoptosis and Cell Cycle Arrest via E2F/Cyclin/CDK Pathway
